Analysis confirms a decade of little drug innovation.
- Published in:
- 2002
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2002 AND VI 37 AND IP 7
Results: 48
1
2
Guideline adherence: which strategy works best?
- Published in:
- 2002
- Publication type:
- Journal Article
3
Market share shift analysis identifies potential impact of atypical antipsychotic formulary addition on budget.
- Published in:
- 2002
- Publication type:
- Journal Article
4
The six-step process for conducting outcomes analyses using administrative databases.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
5
Beyond hypertension: evidence for use of angiotensin II receptor blockers in renal dysfunction and heart failure.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
6
Alefacept: a T-cell-specific immunosuppressant to treat moderate to severe plaque psoriasis.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
7
Cox-2 (mis)use prevalent.
- Published in:
- 2002
- Publication type:
- Journal Article
8
Changes in HMO formulary issues-- 2000 vs 1999.
- Published in:
- 2002
- Publication type:
- Journal Article
9
Simvastatin: myopathy risk.
- Published in:
- 2002
- Publication type:
- Journal Article
10
Drug and formulary factoids.
- Published in:
- 2002
- Publication type:
- Journal Article
11
Recently issued statements and guidelines:.
- Published in:
- 2002
- Publication type:
- Journal Article
12
Did naproxen's cardioprotective effect skew safety data on rofecoxib?
- Published in:
- 2002
- Publication type:
- Journal Article
13
Infliximab could provide new long-term option for Crohn's disease.
- Published in:
- 2002
- Publication type:
- Journal Article
14
Drug shortage update.
- Published in:
- 2002
- Publication type:
- Journal Article
15
Only 15% of new drugs approved in 1989-2000 were highly innovative priority NMEs.
- Published in:
- 2002
- Publication type:
- Journal Article
16
Clinicians alerted to Seroquel/Serzone confusion.
- Published in:
- 2002
- Publication type:
- Journal Article
17
Liver toxicity risk low with rosiglitazone.
- Published in:
- 2002
- Publication type:
- Journal Article
18
Uterine sarcoma linked with long-term tamoxifen use.
- Published in:
- 2002
- Publication type:
- Journal Article
19
Baclofen black box warns against abrupt discontinuation.
- Published in:
- 2002
- Publication type:
- Journal Article
20
CLASS study, updated GI, CV risk info, added to celecoxib label.
- Published in:
- 2002
- Publication type:
- Journal Article
21
No link between hepatitis B vaccine and neurologic disorders.
- Published in:
- 2002
- Publication type:
- Journal Article
22
Early statin use after MI may increase second-event risk for some.
- Published in:
- 2002
- Publication type:
- Journal Article
23
Return to market.
- Published in:
- 2002
- Publication type:
- Journal Article
24
New indications.
- Published in:
- 2002
- Publication type:
- Journal Article
25
First-time generic approvals.
- Published in:
- 2002
- Publication type:
- Journal Article
26
Upcoming advisory meetings.
- Published in:
- 2002
- Publication type:
- Journal Article
27
Fast-track designations.
- Published in:
- 2002
- Publication type:
- Journal Article
28
Orphan drug designations.
- Published in:
- 2002
- Publication type:
- Journal Article
29
Recommendations for approval.
- Published in:
- 2002
- Publication type:
- Journal Article
30
Not approvable.
- Published in:
- 2002
- Publication type:
- Journal Article
31
Approvable designations.
- Published in:
- 2002
- Publication type:
- Journal Article
32
Diabetes and related disorders.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 370
- Publication type:
- Article
33
Congress expands drug safety surveillance as part of bioterrorism bill.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 368
- By:
- Publication type:
- Article
34
Market share shift analysis identifies potential impact of atypical antipsychotic formulary addition on budget.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 367
- By:
- Publication type:
- Article
35
The six-step process for conducting outcomes analyses using administrative databases.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 362
- By:
- Publication type:
- Article
36
Beyond hypertension: Evidence for use of angiotensin II receptor blockers in renal dysfunction and heart failure.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 354
- By:
- Publication type:
- Article
37
Alefacept.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 346
- By:
- Publication type:
- Article
38
NEW PUBLISHED STUDIES OF INTEREST TO DRUG DECISION-MAKERS.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 342
- Publication type:
- Article
39
Tegaserod meta-analysis: Global relief of IBS symptoms, no increase in abdominal surgery.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 341
- Publication type:
- Article
40
Multiple studies show eplerenone to be a potent antihypertensive agent.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 338
- Publication type:
- Article
41
No decline in GI cotherapy or healthcare costs with switch to COX-2 selective drugs.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 338
- Publication type:
- Article
42
Drug shortage update.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 337
- Publication type:
- Article
43
Liver toxicity risk low with rosiglitazone.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 337
- Publication type:
- Article
44
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 336
- Publication type:
- Article
45
No link between hepatitis B vaccine and neurologic disorders.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 336
- Publication type:
- Article
46
FDA actions in brief.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 331
- Publication type:
- Article
47
Early statin use after MI may increase second-event risk for some.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 336
- Publication type:
- Article
48
FDA Drug Approvals.
- Published in:
- Formulary, 2002, v. 37, n. 7, p. 330
- Publication type:
- Article